Clinical Trial

Assessing Medical Menstrual Regulation in the United States

Study Description

Assessing Medical Menstrual Regulation in the United States

This study will assess the acceptability and use of medical menstrual regulation among women in the United States.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Mifepristone

All participants will receive 200 mg mifepristone, to be taken orally on day 1.

Drug - Misoprostol

All participants will receive 800 mcg misoprostol, to be taken buccally 24 hours after mifepristone (day 2)

Additional Information

Official Study Title

Assessing Acceptability and Use of Medical Menstrual Regulation in the United States

Clinical Trial ID

NCT03972358

ParticipAid ID

e9rNJa